content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001635075</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001635088</issuerCik>
        <issuerName>Roivant Sciences LTD</issuerName>
        <secFileNumber>001-40782</secFileNumber>
        <issuerAddress>
          <com:street1>C/o Roivant 7th floor</com:street1>
          <com:street2>50 Broadway</com:street2>
          <com:city>London</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H 0DB</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>44207 400 3347</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Ramaswamy Vivek</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Rockefeller Financial LLC</name>
          <address>
            <com:street1>45 Rockefeller Plaza - Floor 5</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10111</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>382203</noOfUnitsSold>
        <aggregateMarketValue>355830993.00</aggregateMarketValue>
        <noOfUnitsOutstanding>758427350</noOfUnitsOutstanding>
        <approxSaleDate>05/30/2023</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>05/27/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Capped Value Appreciation Rights granted under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>382203</amountOfSecuritiesAcquired>
        <paymentDate>05/27/2023</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>05/30/2023</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>02/23/2023</planAdoptionDate>
        </planAdoptionDates>
        <signature>Jason Coleman as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Vivek Ramaswamy</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3113}]
text: 144
  0001635075
  XXXXXXXX
  LIVE
  0001635088
  Roivant Sciences LTD
  001-40782
  C/o Roivant 7th floor
  50 Broadway
  London
  X0
  SW1H 0DB
  44207 400 3347
  Ramaswamy Vivek
  10% Stockholder
  common
  Rockefeller Financial LLC
  45 Rockefeller Plaza - Floor 5
  New York
  NY
  10111
  382203
  355830993.00
  758427350
  05/30/2023
  NASDAQ
  Common
  05/27/2023
  Capped Value Appreciation Rights granted under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan
  Roivant Sciences Ltd.
  N
  382203
  05/27/2023
  N/A
  Y
  05/30/2023
  02/23/2023
  Jason Coleman as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Vivek Ramaswamy